Correction

Randomized phase III study of high-dose methotrexate and whole-brain radiotherapy with/without temozolomide for newly diagnosed primary CNS lymphoma: JCOG1114C (Nov, noac246, 2022)

Journal

NEURO-ONCOLOGY
Volume 25, Issue 3, Pages 615-615

Publisher

OXFORD UNIV PRESS INC
DOI: 10.1093/neuonc/noad026

Keywords

-

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Recommended

No Data Available
No Data Available